No headlines found.
CALIFORNIA BANCORP DECLARES CASH DIVIDEND
Globe Newswire (Thu, 12-Mar 4:30 PM ET)
Globe Newswire (Wed, 28-Jan 8:00 AM ET)
CALIFORNIA BANK OF COMMERCE ADDS TWO VETERAN COMMERCIAL BANKERS TO ITS NORTHERN CALIFORNIA TEAM
Globe Newswire (Mon, 26-Jan 8:00 AM ET)
CALIFORNIA BANCORP ANNOUNCES RETIREMENT OF CEO STEVEN SHELTON AND APPOINTMENT OF DAVID RAINER AS CEO
Globe Newswire (Wed, 7-Jan 8:00 AM ET)
California BanCorp is a relationship-focused community bank offering commercial loan and deposit products, along with other services delivered directly or through strategic alliances, to business and individual customers in its target markets. The Company provides financial products and services to individuals, professionals, and small to medium-sized businesses through its branch and commercial banking offices serving California. Its lending products consist mainly of construction and land development loans, real estate loans, C&I loans, and consumer loans, and it is a Preferred SBA Lender, while its deposit products consist mainly of demand deposit, money market, and certificates of deposit. The Company operates in one reportable segment, commercial banking.
California Bancorp trades on the NASDAQ stock market under the symbol BCAL.
As of April 2, 2026, BCAL stock price declined to $17.76 with 135,349 million shares trading.
BCAL has a beta of 1.13, meaning it tends to be more sensitive to market movements. BCAL has a correlation of 0.40 to the broad based SPY ETF.
BCAL has a market cap of $574.13 million. This is considered a Small Cap stock.
Last quarter California Bancorp reported $46 million in Revenue and $.50 earnings per share. This beat revenue expectation by $868,000 and exceeded earnings estimates by $.06.
The top ETF exchange traded funds that BCAL belongs to (by Net Assets): VTI, IWM, KRE, AVUV, VXF.
BCAL has outperformed the market in the last year with a price return of +27.2% while the SPY ETF gained +18.2%. However, in the short term, BCAL had mixed performance relative to the market. It has underperformed in the last 3 months, returning -4.3% vs -3.6% return in SPY. But in the last 2 weeks, BCAL shares have fared better than the market returning +3.1% compared to SPY -0.6%.
BCAL support price is $17.51 and resistance is $18.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCAL shares will trade within this expected range on the day.